Manu Jaggi
About
Manu Jaggi is a scholar working on Molecular Biology, Oncology and Organic Chemistry.
According to data from OpenAlex, Manu Jaggi has authored 78 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 25 papers in Oncology and 14 papers in Organic Chemistry. Recurrent topics in Manu Jaggi's work include Cancer therapeutics and mechanisms (15 papers), Drug Transport and Resistance Mechanisms (14 papers) and Natural product bioactivities and synthesis (13 papers). Manu Jaggi is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Drug Transport and Resistance Mechanisms (14 papers) and Natural product bioactivities and synthesis (13 papers). Manu Jaggi collaborates with scholars based in India, Czechia and Pakistan. Manu Jaggi's co-authors include Sushama Talegaonkar, Tripta Bansal, Obaid Afzal, Sandhya Bawa, Rajiv Kumar, Md Rahmat Ali, Suresh Kumar, Md Rafi Haider, Alka Madaan and Lalit Negi and has published in prestigious journals such as Journal of Clinical Oncology, Carbohydrate Polymers and International Journal of Pharmaceutics.
In The Last Decade
Manu Jaggi
77 papers receiving 3.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Manu Jaggi India | 30 | 1.3k | 940 | 689 | 436 | 409 | 78 | 3.1k | ||
| Hongtao Xu China | 33 | 1.7k 1.3× | 1.2k 1.2× | 230 0.3× | 293 0.7× | 261 0.6× | 115 | 3.2k | ||
| Santosh Kumar Guru India | 34 | 1.3k 1.0× | 849 0.9× | 340 0.5× | 182 0.4× | 364 0.9× | 120 | 2.9k | ||
| Mario Sechi Italy | 41 | 1.5k 1.2× | 948 1.0× | 399 0.6× | 223 0.5× | 777 1.9× | 96 | 4.0k | ||
| Vivek R. Yadav United States | 28 | 1.7k 1.3× | 410 0.4× | 381 0.6× | 264 0.6× | 272 0.7× | 60 | 3.5k | ||
| V. Badireenath Konkimalla India | 24 | 1.2k 0.9× | 473 0.5× | 367 0.5× | 162 0.4× | 778 1.9× | 80 | 3.2k | ||
| Piyush Trivedi India | 26 | 993 0.8× | 1.0k 1.1× | 240 0.3× | 239 0.5× | 198 0.5× | 144 | 2.5k | ||
| Ruby John Anto India | 34 | 1.9k 1.5× | 633 0.7× | 383 0.6× | 122 0.3× | 333 0.8× | 80 | 3.8k | ||
| Sushil K. Kashaw India | 29 | 1.6k 1.2× | 1.6k 1.7× | 1.2k 1.7× | 276 0.6× | 534 1.3× | 131 | 4.7k | ||
| Antonio Garofalo Italy | 31 | 1.2k 1.0× | 1.2k 1.3× | 531 0.8× | 112 0.3× | 198 0.5× | 119 | 3.2k | ||
| Panayiotis P. Constantinides United States | 24 | 854 0.7× | 476 0.5× | 361 0.5× | 1.2k 2.8× | 371 0.9× | 42 | 2.7k |
Countries citing papers authored by Manu Jaggi
Since
Specialization
Citations
This map shows the geographic impact of Manu Jaggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manu Jaggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manu Jaggi more than expected).
Fields of papers citing papers by Manu Jaggi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Manu Jaggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manu Jaggi. The network helps show where Manu Jaggi may publish in the future.
Co-authorship network of co-authors of Manu Jaggi
This figure shows the co-authorship network connecting the top 25 collaborators of Manu Jaggi. A scholar is included among the top collaborators of Manu Jaggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manu Jaggi. Manu Jaggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Siddiqui, Lubna, Nazeer Hasan, Pawan Kumar Mishra, et al.. (2023). CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies. International Journal of Pharmaceutics. 643. 123270–123270.
2.
Rabbani, Syed Arman, Yub Raj Neupane, Shweta Pandey, et al.. (2020). Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis. Carbohydrate Polymers. 250. 116926–116926.
3.
Madaan, Alka, et al.. (2017). In vitro Hair Growth Promoting Effects of Naringenin and Hesperetin on Human Dermal Papilla Cells and Keratinocytes. 6(3). 51–57.
4.
Pandit, Subrata, Satyajyoti Kanjilal, Anshumali Awasthi, et al.. (2016). Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay. Journal of Ethnopharmacology. 197. 165–172.
5.
Afzal, Obaid, Md Sayeed Akhtar, Suresh Kumar, et al.. (2016). Hit to lead optimization of a series of N-[4-(1,3-benzothiazol-2-yl)phenyl]acetamides as monoacylglycerol lipase inhibitors with potential anticancer activity. European Journal of Medicinal Chemistry. 121. 318–330.
6.
Bawa, Sandhya, Obaid Afzal, Suresh Kumar, Rajiv Kumar, & Manu Jaggi. (2014). 3D-QSAR study of benzotriazol-1-yl carboxamide scaffold as monoacylglycerol lipase inhibitors. Journal of Pharmacy And Bioallied Sciences. 6(4). 260–260.
7.
Afzal, Obaid, Suresh Kumar, Rajiv Kumar, et al.. (2014). Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(16). 3986–3996.
8.
Awasthi, Anshumali, Mohtashim Lohani, Manoj Kumar Singh, Anu Singh, & Manu Jaggi. (2013). Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding. Journal of Enzyme Inhibition and Medicinal Chemistry. 29(5). 710–721.
9.
Negi, Lalit, Manu Jaggi, & Sushama Talegaonkar. (2013). Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. International Journal of Pharmaceutics. 461(1-2). 403–410.
10.
Madaan, Alka, Vivek Kumar, Ritu Verma, et al.. (2013). Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide) possessing in vitro anticancer potential. International Immunopharmacology. 15(3). 606–613.
11.
Negi, Lalit, Manu Jaggi, & Sushama Talegaonkar. (2013). Addressing the potential toxicities of the non-specific P-glycoprotein modulation by amalgamation with targeted approach in MDR tumors. Medical Hypotheses. 82(2). 240–242.
12.
Negi, Lalit, Manu Jaggi, & Sushama Talegaonkar. (2012). A logical approach to optimize the nanostructured lipid carrier system of irinotecan: efficient hybrid design methodology. Nanotechnology. 24(1). 15104–15104.
13.
Akhtar, Naseem, Sushama Talegaonkar, Roop K. Khar, et al.. (2011). A STABILITY INDICATING HPTLC METHOD FOR THE ANALYSIS OF IRINOTECAN IN BULK DRUG AND MARKETED INJECTABLES. Journal of Liquid Chromatography & Related Technologies. 34(14). 1459–1472.
14.
Bansal, Tripta, Manu Jaggi, Roop Khar, & Sushama Talegaonkar. (2009). Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy. Journal of Pharmacy & Pharmaceutical Sciences. 12(1). 46–46.
15.
Kumar, Vivek, Anu Singh, Manu Jaggi, et al.. (2008). Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 18(18). 5058–5062.
16.
Prasad, S., et al.. (2007). Substance P analogs containing α,α‐dialkylated amino acids with potent anticancer activity. Journal of Peptide Science. 13(8). 544–548.
17.
Bansal, Tripta, Manoj Kumar Singh, Gautam Mishra, et al.. (2007). Concurrent determination of topotecan and model permeability markers (atenolol, antipyrine, propranolol and furosemide) by reversed phase liquid chromatography: Utility in Caco-2 intestinal absorption studies. Journal of Chromatography B. 859(2). 261–266.
18.
Mukherjee, Rama, Manu Jaggi, Jamshed Siddiqui, et al.. (2004). Synthesis and cytotoxic activity of 3-O-acyl/3-hydrazine /2-bromo/20,29-dibromo betulinic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 14(15). 4087–4091.
19.
Mukherjee, Rama, Manu Jaggi, Praveen Rajendran, et al.. (2004). Betulinic acid and its derivatives as anti-angiogenic agents. Bioorganic & Medicinal Chemistry Letters. 14(9). 2181–2184.
20.
Jaggi, Manu & R. K. Khar. (1993). Liposome entrapped 99m tc-glucoheptonate for liver scintigraphy.. Indian Journal of Pharmaceutical Sciences. 55(5).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hongtao Xu Breakdown of academic impact, for papers by Santosh Kumar Guru Breakdown of academic impact, for papers by Mario Sechi Breakdown of academic impact, for papers by Vivek R. Yadav Breakdown of academic impact, for papers by V. Badireenath Konkimalla Breakdown of academic impact, for papers by Piyush Trivedi Breakdown of academic impact, for papers by Ruby John Anto Breakdown of academic impact, for papers by Sushil K. Kashaw Breakdown of academic impact, for papers by Antonio Garofalo Breakdown of academic impact, for papers by Panayiotis P. Constantinides